HAX-1 inhibits apoptosis in prostate cancer through the suppression of caspase-9 activation

Oncology Reports

Volumn 34, Issue 5, 2015, Pages 2776-2781

  Yan, Jiliang ^a   Ma, Chunyan ^a   Cheng, Jian ^b   Li, Zhengguo ^a   Liu, Chao ^c  

^a Kaifeng Eye Hospital   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 9; HS1 associated protein X 1; Prostate cancer

Indexed keywords

CASPASE 9; KI 67 ANTIGEN; PROTEIN HAX 1; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CASP9 PROTEIN, HUMAN; HAX1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INACTIVATION; EXPRESSION VECTOR; GENE; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HAX 1 GENE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROSTATE EPITHELIUM CELL; PROTEIN FUNCTION; PROTEIN INTERACTION; CELL SURVIVAL; GENETICS; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84941978825     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4202     Document Type: Article

References (34)

1. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, et al: The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629, 2002.
2. Tsai HT, Penson DF, Makambi KH, Lynch JH, Van Den Eeden SK and Potosky AL: Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: A meta-analysis. Urology 82: 327-333, 2013.
3. Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U and Watanabe T: HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 158: 2736-2744, 1997.
4. Mirmohammadsadegh A, Tartler U, Michel G, Baer A, Walz M, Wolf R, Ruzicka T and Hengge UR: HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis. J Invest Dermatol 120: 1045-1051, 2003.
5. Sharp TV, Wang H-W, Koumi A, Hollyman D, Endo Y, Ye H, Du MQ and Boshoff C: K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol 76: 802-816, 2002.
6. Trebinska A, Rembiszewska A, Ciosek K, Ptaszynski K, Rowinski S, Kupryjanczyk J, Siedlecki JA and Grzybowska EA: HAX-1 overexpression, splicing and cellular localization in tumors. BMC Cancer 10: 76, 2010.
7. Jing YY, Li XL, Shi Q, Wang ZY, Guo Y, Pan MM, Tian C, Zhu SY, Chen C, Gong HS, et al: A novel PrP partner HS-1 associated protein X-1 (HAX-1) protected the cultured cells against the challenge of H2O2. J Mol Neurosci 45: 216-228, 2011.
8. Wei XJ, Li SY, Yu B, Chen G, Du JF and Cai HY: Expression of HAX-1 in human colorectal cancer and its clinical significance. Tumour Biol 35: 1411-1415, 2014.
9. Shaw J and Kirshenbaum LA: HAX-1 represses postmitochondrial caspase-9 activation and cell death during hypoxia-reoxygenation. Circ Res 99: 336-338, 2006.
10. Mahdavi M, Davoodi J, Zali MR and Foroumadi A: Concomitant activation of caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in HepG2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-chromenes family. Biomed Pharmacother 65: 175-182, 2011.
11. Han Y, Chen YS, Liu Z, Bodyak N, Rigor D, Bisping E, Pu WT and Kang PM: Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res 99: 415-423, 2006.
12. Elstner E, Müller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D and Koeffler HP: Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95: 8806-8811, 1998.
13. Hsieh TC and Wu JM: Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 249: 109-115, 1999.
14. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM and Chen CS: The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275: 11397-11403, 2000.
15. Fulda S: Evasion of apoptosis as a cellular stress response in cancer. Int J Cell Biol 2010: 370835, 2010.
16. Plati J, Bucur O and Khosravi-Far R: Apoptotic cell signaling in cancer progression and therapy. Integr Biol Camb 3: 279-296, 2011.
17. Akgul C: Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 66: 1326-1336, 2009.
18. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D and Nagini S: The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol 649: 84-91, 2010.
19. Li WB, Feng J, Geng SM, Zhang PY, Yan XN, Hu G, Zhang CQ and Shi BJ: Induction of apoptosis by Hax-1 siRNA in melanoma cells. Cell Biol Int 33: 548-554, 2009.
20. Yap SV, Koontz JM and Kontrogianni-Konstantopoulos A: HAX-1: A family of apoptotic regulators in health and disease. J Cell Physiol 226: 2752-2761, 2011.
21. Li M, Tang Y, Zang W, Xuan X, Wang N, Ma Y, Wang Y, Dong Z and Zhao G: Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma. Diagn Pathol 8: 47, 2013.
22. Ferri KF and Kroemer G: Organelle-specific initiation of cell death pathways. Nat Cell Biol 3: E255-E263, 2001.
23. Philchenkov A: Caspases: Potential targets for regulating cell death. J Cell Mol Med 8: 432-444, 2004.
24. Yin C, Knudson CM, Korsmeyer SJ and Van Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640, 1997.
25. Youle RJ and Strasser A: The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59, 2008.
26. Zong WX, Li C, Hatzivassiliou G, Lindsten T, Yu QC, Yuan J and Thompson CB: Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 162: 59-69, 2003.
27. Deveraux QL and Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 13: 239-252, 1999.
28. Fadeel B and Grzybowska E: HAX-1: A multifunctional protein with emerging roles in human disease. Biochim Biophys Acta 1790: 1139-1148, 2009.
29. Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, Gupta S, Bonventre JV, Alnemri ES and Zervos AS: Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 279: 50295-50301, 2004.
30. Gupta K, Thakur VS, Bhaskaran N, Nawab A, Babcook MA, Jackson MW and Gupta S: Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. PLoS One 7: e52572, 2012.
31. Martinou JC and Youle RJ: Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21: 92-101, 2011.
32. Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol 14: 32, 2013.
33. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
34. Srinivasula SM, Ahmad M, Fernandes-Alnemri T and Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1: 949-957, 1998.